323 related articles for article (PubMed ID: 12089360)
1. Regulation and function of the cytokine-inducible SH-2 domain proteins, CIS and SOCS3, in mammary epithelial cells.
Tonko-Geymayer S; Goupille O; Tonko M; Soratroi C; Yoshimura A; Streuli C; Ziemiecki A; Kofler R; Doppler W
Mol Endocrinol; 2002 Jul; 16(7):1680-95. PubMed ID: 12089360
[TBL] [Abstract][Full Text] [Related]
2. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
3. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
Selvaraj NG; Omi E; Gibori G; Rao MC
Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.
Welte T; Garimorth K; Philipp S; Doppler W
Mol Endocrinol; 1994 Aug; 8(8):1091-102. PubMed ID: 7527899
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific induction of SOCS gene expression by PRL.
Tam SP; Lau P; Djiane J; Hilton DJ; Waters MJ
Endocrinology; 2001 Nov; 142(11):5015-26. PubMed ID: 11606470
[TBL] [Abstract][Full Text] [Related]
6. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
7. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mammary gland factor/Stat5a during mammary gland development.
Kazansky AV; Raught B; Lindsey SM; Wang YF; Rosen JM
Mol Endocrinol; 1995 Nov; 9(11):1598-609. PubMed ID: 8584036
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling.
Helman D; Sandowski Y; Cohen Y; Matsumoto A; Yoshimura A; Merchav S; Gertler A
FEBS Lett; 1998 Dec; 441(2):287-91. PubMed ID: 9883901
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.
Park DS; Lee H; Frank PG; Razani B; Nguyen AV; Parlow AF; Russell RG; Hulit J; Pestell RG; Lisanti MP
Mol Biol Cell; 2002 Oct; 13(10):3416-30. PubMed ID: 12388746
[TBL] [Abstract][Full Text] [Related]
13. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.
Matsumoto A; Seki Y; Kubo M; Ohtsuka S; Suzuki A; Hayashi I; Tsuji K; Nakahata T; Okabe M; Yamada S; Yoshimura A
Mol Cell Biol; 1999 Sep; 19(9):6396-407. PubMed ID: 10454585
[TBL] [Abstract][Full Text] [Related]
14. LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits β-casein synthesis in bovine mammary epithelial cells.
Geng Z; Shan X; Lian S; Wang J; Wu R
Life Sci; 2021 Aug; 278():119547. PubMed ID: 33930363
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying the diminished sensitivity to prolactin negative feedback during lactation: reduced STAT5 signaling and up-regulation of cytokine-inducible SH2 domain-containing protein (CIS) expression in tuberoinfundibular dopaminergic neurons.
Anderson ST; Barclay JL; Fanning KJ; Kusters DH; Waters MJ; Curlewis JD
Endocrinology; 2006 Mar; 147(3):1195-202. PubMed ID: 16357045
[TBL] [Abstract][Full Text] [Related]
16. Mammary gland factor activated by prolactin on mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential.
Standke GJ; Meier VS; Groner B
Mol Endocrinol; 1994 Apr; 8(4):469-77. PubMed ID: 7519723
[TBL] [Abstract][Full Text] [Related]
17. SOCS3 promotes apoptosis of mammary differentiated cells.
Le Provost F; Miyoshi K; Vilotte JL; Bierie B; Robinson GW; Hennighausen L
Biochem Biophys Res Commun; 2005 Dec; 338(4):1696-701. PubMed ID: 16289036
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor functional activity changes during differentiation of mammary epithelial cells.
Faulds MH; Olsen H; Helguero LA; Gustafsson JA; Haldosén LA
Mol Endocrinol; 2004 Feb; 18(2):412-21. PubMed ID: 14605098
[TBL] [Abstract][Full Text] [Related]
20. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
